A study of analyst recommendations at the major brokerages shows that Johnson & Johnson (Symbol: JNJ) is the #10 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel. Johnson & Johnson also comes in above the median of analyst picks among the broader S&P 500 index components, claiming the #120 spot out of 500.
Below is a chart of rank over time:
JNJ operates in the Drugs & Pharmaceuticals sector, among companies like Eli Lilly (LLY) which is up about 0.6% today, and Novartis (NVS) trading lower by about 0.2%. Below is a three month price history chart comparing the stock performance of JNJ, versus LLY and NVS.
JNJ is currently trading up about 1.4% midday Tuesday.
15 Forgotten Giants of the S&P 500: Analysts’ Current Least Favorites »
Also see:
Cathie Wood Stock Picks
UE Historical Stock Prices
DividendRank Canada
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
www.nasdaq.com